Metrics as of 10/17/2026, 08:53 AM (Berlin time), refresh in progress.
Roche Holding AG
Roche Holding AG is a research healthcare company headquartered in Basel, Switzerland. Founded by Fritz Hoffmann-La Roche on October 1, 1896, the company currently employs 112,774 employees. The business operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceuticals segment comprises…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
-1.0%
1W
+5.5%
1M
+3.7%
6M
+19.8%
YTD
+15.7%
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
04/02/2027 (in 110 days)
Volatility around earnings
~27% stronger price swings than usual
FREE FLOAT
–
FLOAT SHARES
688,926,637
AVG. DAILY VOLUME (30D)
1,380
Roche Holding AG is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in Switzerland.
The CEO is Thomas Schinecker, the company employs around 112,774 people.
The IPO was on 23/10/2025; the stock trades on TSX under the ticker ROG.TO.
The next earnings date is 04/02/2027.
Around past earnings, price swings were roughly 27% stronger than usual.
Yes. The last dividend was CA$0.50 per share, ex-date 13/03/2026, paid on 23/03/2026.
Comparable stocks include Roche Holding, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences and Pfizer.
Clicking "Analyze stock" lets five strategies assess Roche Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.